Skip to main content
GenMont logo

GenMont — Investor Relations & Filings

Ticker · 3164 ISIN · TW0003164000 TW Manufacturing
Open in API
Filings indexed 1,625 across all filing types
Latest filing 2013-02-06 Director's Dealing
Country TW Taiwan
Listing TW 3164

About GenMont

www.genmont.com.tw

GenMont Biotech Inc. specializes in the research, development, and manufacturing of functional probiotics and postbiotics. The company operates advanced fermentation and production platforms for concentrated fermented milk, lactic acid bacteria powders, and functional microorganism strains. Its product portfolio features patented probiotic solutions targeting diverse health areas, including immune modulation, metabolic health, dental hygiene, digestive function, weight management, and pet wellness. Key proprietary strains include L. paracasei 33 and GMNL-32. GenMont leverages its technology platforms and extensive patent portfolio to deliver scientifically-backed health supplements. Beyond its proprietary brands, the company provides original equipment manufacturing (OEM) services, supporting the global market with high-quality probiotic and postbiotic ingredients certified by international standards.

Recent filings

Filing Released Lang Actions
102年01月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document contains detailed tabular data about shareholdings of company insiders, including directors, supervisors, and senior management, with specific numbers of shares held, changes in holdings, and classifications of shares. The content is focused on insider shareholding disclosures rather than financial results, management changes, or meeting materials. There is no indication of financial statements, earnings data, or meeting results. The document is a report of personal share transactions and holdings by company directors and executives, which fits the definition of Director's Dealing (DIRS). The document length is sufficient to be a full report, not just an announcement. Therefore, the appropriate classification is DIRS.
2013-02-06 Chinese
102年01月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, supervisors, and senior management. It focuses on the personal shareholdings and pledges of insiders rather than financial results, management changes, or other corporate events. The presence of insider names, titles, and shareholding details strongly indicates this is a report on insider share transactions or holdings. There is no indication of a full financial report, earnings release, or meeting materials. The document length is 2420 characters, which is relatively short but contains detailed insider shareholding data. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades).
2013-02-06 Chinese
101年12月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, supervisors, and senior management, with specific data on stock types, quantities held at different times, and changes during the month. The content focuses on insider shareholding disclosures rather than financial results, management changes, or meeting materials. There is no indication of an annual report, earnings release, or other financial report. The document is a regulatory disclosure of insider shareholdings, which aligns with the definition of Director's Dealing (DIRS) filings, reporting personal share transactions by company directors and executives. The document length is sufficient and contains substantive data, not just an announcement or certification. Therefore, the appropriate classification is DIRS.
2013-01-11 Chinese
101年12月董事會成員及持股
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings and pledged shares of company insiders, including directors, supervisors, and senior management. It focuses on insider shareholdings and pledges, with no financial statements, earnings data, or meeting results. The content matches the description of a Director's Dealing report, which reports personal share transactions or holdings by company directors and executives. The document length is 2420 characters, which is short but contains substantive insider shareholding data, not just an announcement or certification. Therefore, the appropriate classification is Director's Dealing (DIRS).
2013-01-11 Chinese
公告本公司申請股票上櫃轉上市時所出具之承諾事項 暨其後續執行情形
Regulatory Filings Classification · 95% confidence The document is a regulatory announcement from a listed company (景岳生物科技股份有限公司) regarding commitments made when applying for stock listing transfer and the subsequent execution status. It references compliance with Taiwan Stock Exchange regulations and details specific commitments and follow-up actions. The document length is short (1124 characters) and it primarily reports on compliance and corporate governance matters rather than presenting financial statements or detailed financial data. It does not contain financial results, audit opinions, or management discussion. Therefore, it fits best as a Regulatory Filing (RNS), which is a general regulatory announcement that does not fit other specific categories.
2013-01-04 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.